Home > Insider Trading > Filing (0000890465-13-000035)

Filing Details

Accession Number:: 0000890465-13-000035
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-19 17:51:44
Reporting Period:: 2013-12-17

Filing Date:: 2013-12-19
Accepted Time:: 2013-12-19 17:51:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
890465	Nps Pharmaceuticals Inc	NPSP	Biological Products, (No Disgnostic Substances) (2836)	870439579

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1474064	Ed Stratemeier	550 Hills Drive Bedminster NJ 07921	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-12-17	50,972	$3.60	93,311	No	4	M	Direct
Common Stock	Disposition	2013-12-17	50,972	$25.00	42,339	No	4	S	Direct
Common Stock	Acquisiton	2013-12-18	34,473	$3.60	76,812	No	4	M	Direct
Common Stock	Acquisiton	2013-12-18	50,625	$3.34	127,437	No	4	M	Direct
Common Stock	Acquisiton	2013-12-18	43,750	$6.16	171,187	No	4	M	Direct
Common Stock	Acquisiton	2013-12-18	14,062	$8.25	185,249	No	4	M	Direct
Common Stock	Acquisiton	2013-12-18	11,550	$8.21	196,799	No	4	M	Direct
Common Stock	Disposition	2013-12-18	154,460	$25.17	42,339	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2013-12-17	50,972	$0.00	50,972	$3.60
Common Stock	Stock Options	Disposition	2013-12-18	34,473	$0.00	34,473	$3.60
Common Stock	Stock Options	Disposition	2013-12-18	50,625	$0.00	50,625	$3.34
Common Stock	Stock Options	Disposition	2013-12-18	43,750	$0.00	43,750	$6.16
Common Stock	Stock Options	Disposition	2013-12-18	14,062	$0.00	14,062	$8.25
Common Stock	Stock Options	Disposition	2013-12-18	11,550	$0.00	11,550	$8.21

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
34,473	2019-10-19	No	4	M	Direct
0	2019-10-19	No	4	M	Direct
39,375	2020-02-19	No	4	M	Direct
6,250	2020-05-07	No	4	M	Direct
8,438	2021-02-17	No	4	M	Direct
14,850	2022-02-07	No	4	M	Direct

Footnotes

The exercises and sales made by the Reporting Person and disclosed in this Form 4 are in anticipation of his retirement, which was disclosed in a Form 8-K filed by the Issuer with the Securities and Exchange Commission today, December 19, 2013.
The shares were sold pursuant to a predefined price target in a trading plan qualified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, that was effective December 13, 2013.
The price shown above represents the weighted average price of the shares sold. The range of sales prices was $25.00 and $25.46. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
On October 19, 2009, the Reporting Person received a grant of 100,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, 100,000 stock options have vested.
On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. As of December 18, 2013, the performance criteria for 50,625 of these options has been satisfied. The options become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.
On May 7, 2010, the Reporting Person received a grant of 50,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, 43,750 stock options have vested.
On February 17, 2011, the Reporting Person received a grant of 22,500 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, 15,468 stock options have vested.
On February 7, 2012, the Reporting Person received a grant of 26,400 stock options under the Issuer's 2005 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter. As of the date of this filing, 11,550 stock options have vested.